Aurinia Pharmaceuticals Inc. (AUPH)

NASDAQ: AUPH · Real-Time Price · USD

14.40

0.00 (0.00%)

Feb 20, 2026, 4:00 PM EST - Market closed

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Research, Development and Commercialization of Therapeutic Drugs	235.13M	175.51M	134.03M	45.61M	50.12M
Research, Development and Commercialization of Therapeutic Drugs Growth	33.97%	30.95%	193.89%	-9.00%	15660.38%
Total	235.13M	175.51M	134.03M	45.61M	50.12M
Total Growth	33.97%	30.95%	193.89%	-9.00%	15660.38%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
United States	210.10M	157.96M	102.46M	45.49M	-
United States Growth	33.01%	54.17%	125.25%	-	-
Japan	25.04M	17.56M	31.48M	-	50.00M
Japan Growth	42.63%	-44.24%	-	-	-
Other	-	-	89.00K	117.00K	118.00K
Other Growth	-	-	-23.93%	-0.85%	0%
Total	235.13M	175.51M	134.03M	45.61M	50.12M
Total Growth	33.97%	30.95%	193.89%	-9.00%	15660.38%

Source: S&P Global Market Intelligence.